Skip to main content
Top
Published in: Journal of Cancer Research and Clinical Oncology 9/2021

Open Access 01-09-2021 | Melanoma | Original Article – Clinical Oncology

Multivariate analysis of prognostic factors in patients with nodular melanoma

Authors: L. Susok, M. Stücker, F. G. Bechara, E. Stockfleth, T. Gambichler

Published in: Journal of Cancer Research and Clinical Oncology | Issue 9/2021

Login to get access

Abstract

Purpose

Nodular melanoma (NM) is associated with worse disease outcome when compared to superficial spreading melanoma (SSM). We aimed to perform a single-center analysis of prognostic factors in patients with NM and compare the data with SSM patients.

Methods

We studied 228 patients with NN and 396 patients with SSM. Patients with in situ melanomas or stage IV at diagnosis were not included in the study. Data were analyzed using the Mann–Whitney test, Chi-square test, Kaplan–Meier curves including the log-rank test, and logistic regression model.

Results

When compared to patients with SSM, patients with NM had less likely lower Clark level, higher tumor thickness, less likely tumor regression, more often ulcerated tumors, and less likely a history of precursor lesions such as a nevus. Within a 5-year follow-up we observed significantly more disease relapses and deaths in NM patients than in SSM patients. On multivariate analysis, disease relapse in NM patients was independently predicted by tumor thickness and positive SLNB, whereas melanoma-specific death of NM patients was independently predicted by male sex and tumor thickness. Histologic regression also remained in the logistic regression model as a significant independent negative predictor of NM death.

Conclusions

We did not observe that NM subtype was per se a significant independent predictor for disease relapse or melanoma-specific death. Among the well-known prognostic factors such as tumor thickness and male sex, NM is also associated with other unfavorable factors such as absence of regression.
Literature
go back to reference Allais BS, Beatson M, Wang H, Shahbazi S, Bijelic L, Jang S, Venna S (2020) Five-year survival in patients with nodular and superficial spreading melanomas in the US population. J Am AcadDermatol 27:190–9622 Allais BS, Beatson M, Wang H, Shahbazi S, Bijelic L, Jang S, Venna S (2020) Five-year survival in patients with nodular and superficial spreading melanomas in the US population. J Am AcadDermatol 27:190–9622
go back to reference Balch CM, Gershenwald JE, Soong S-J et al (2009) Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 27:6199–6206CrossRef Balch CM, Gershenwald JE, Soong S-J et al (2009) Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 27:6199–6206CrossRef
go back to reference Barnhill RL, Fine JA, Roush GC, Berwick M (2020) Predicting five-year outcome for patients with cutaneous melanoma in a population-based study. Cancer 78:427–432CrossRef Barnhill RL, Fine JA, Roush GC, Berwick M (2020) Predicting five-year outcome for patients with cutaneous melanoma in a population-based study. Cancer 78:427–432CrossRef
go back to reference Chamberlain AJ, Fritschi L, Giles GG, Dowling JP, Kelly JW (2002) (1996) Nodular type and older age as the most significant associations of thick melanoma in Victoria, Australia. Arch Dermatol 138(5):609CrossRef Chamberlain AJ, Fritschi L, Giles GG, Dowling JP, Kelly JW (2002) (1996) Nodular type and older age as the most significant associations of thick melanoma in Victoria, Australia. Arch Dermatol 138(5):609CrossRef
go back to reference Dessinioti C, Geller AC, Stergiopoulou A et al (2018) Association of skin examination behaviors and thinner nodular vs superficial spreading melanoma at diagnosis. JAMADermatol 154:544–553 Dessinioti C, Geller AC, Stergiopoulou A et al (2018) Association of skin examination behaviors and thinner nodular vs superficial spreading melanoma at diagnosis. JAMADermatol 154:544–553
go back to reference Dessinioti C, Dimou N, Geller AC, Stergiopoulou A, Lo S, Keim U, Gershenwald JE, Haydu LE, Ribero S, Quaglino P, Puig S, Malvehy J, Kandolf-Sekulovic L, Radevic T, Kaufmann R, Meister L, Nagore E, Traves V, Champsas GG, Plaka M, Dreno B, Varey E, Ramirez DM, Dummer R, Mangana J, Hauschild A, Egberts F, Peris K, Del Regno L, Forsea AM, Zurac SA, Vieira R, Brinca A, Zalaudek I, Deinlein T, Linos E, Evangelou E, Thompson JF, Scolyer RA, Garbe C, Stratigos AJ (2019) Distinct clinicopathological and prognostic features of thin nodular primary melanomas: an international study from 17 centers. J Natl Cancer Inst 111:1314–1322CrossRef Dessinioti C, Dimou N, Geller AC, Stergiopoulou A, Lo S, Keim U, Gershenwald JE, Haydu LE, Ribero S, Quaglino P, Puig S, Malvehy J, Kandolf-Sekulovic L, Radevic T, Kaufmann R, Meister L, Nagore E, Traves V, Champsas GG, Plaka M, Dreno B, Varey E, Ramirez DM, Dummer R, Mangana J, Hauschild A, Egberts F, Peris K, Del Regno L, Forsea AM, Zurac SA, Vieira R, Brinca A, Zalaudek I, Deinlein T, Linos E, Evangelou E, Thompson JF, Scolyer RA, Garbe C, Stratigos AJ (2019) Distinct clinicopathological and prognostic features of thin nodular primary melanomas: an international study from 17 centers. J Natl Cancer Inst 111:1314–1322CrossRef
go back to reference El Sharouni MA, van Diest PJ, Witkamp AJ, Sigurdsson V, van Gils CH (2020) Subtyping cutaneous melanoma matters. JNCI Cancer Spectr 4:pkaa097CrossRef El Sharouni MA, van Diest PJ, Witkamp AJ, Sigurdsson V, van Gils CH (2020) Subtyping cutaneous melanoma matters. JNCI Cancer Spectr 4:pkaa097CrossRef
go back to reference Faut M, Wevers KP, van Ginkel RJ et al (2017) Nodular histologic subtype and ulceration are tumor factors associated with high risk of recurrence in sentinel node-negative melanoma patients. Ann Surg Oncol 24:142–149CrossRef Faut M, Wevers KP, van Ginkel RJ et al (2017) Nodular histologic subtype and ulceration are tumor factors associated with high risk of recurrence in sentinel node-negative melanoma patients. Ann Surg Oncol 24:142–149CrossRef
go back to reference Garbe C, Hauschild A, Volkenandt M, Schadendorf D, Stolz W, Kortmann R-D, Kaufmann R (2006) Brief guidelines: malignant melanoma of the skin [Kurzleitlinie: Malignes Melanom der Haut]. JDDG J Dtsch Dermatol Ges 4:344–349CrossRef Garbe C, Hauschild A, Volkenandt M, Schadendorf D, Stolz W, Kortmann R-D, Kaufmann R (2006) Brief guidelines: malignant melanoma of the skin [Kurzleitlinie: Malignes Melanom der Haut]. JDDG J Dtsch Dermatol Ges 4:344–349CrossRef
go back to reference Green AC, Baade P, Coory M, Aitken JF, Smithers M (2012) Population-based 20-year survival among people diagnosed with thin melanomas in Queensland Australia. J Clin Oncol 30:1462–1467CrossRef Green AC, Baade P, Coory M, Aitken JF, Smithers M (2012) Population-based 20-year survival among people diagnosed with thin melanomas in Queensland Australia. J Clin Oncol 30:1462–1467CrossRef
go back to reference Greenwald HS, Friedman EB, Osman I (2012) Superficial spreading and nodular melanoma are distinct biological entities: a challenge to the linear progression model. Melanoma Res 22:1–8CrossRef Greenwald HS, Friedman EB, Osman I (2012) Superficial spreading and nodular melanoma are distinct biological entities: a challenge to the linear progression model. Melanoma Res 22:1–8CrossRef
go back to reference Lattanzi M, Lee Y, Simpson D, Moran U, Darvishian F, Kim RH, Hernando E, Polsky D, Hanniford D, Shapiro R, Berman R, Pavlick AC, Wilson MA, Kirchhoff T, Weber JS, Zhong J, Osman I (2019) Primary melanoma histologic subtype: impact on survival and response to therapy. J Natl Cancer Inst 111:180–188CrossRef Lattanzi M, Lee Y, Simpson D, Moran U, Darvishian F, Kim RH, Hernando E, Polsky D, Hanniford D, Shapiro R, Berman R, Pavlick AC, Wilson MA, Kirchhoff T, Weber JS, Zhong J, Osman I (2019) Primary melanoma histologic subtype: impact on survival and response to therapy. J Natl Cancer Inst 111:180–188CrossRef
go back to reference Lindholm C, Andersson R, Dufmats M, Hansson J, Ingvar C, Möller T, Sjödin H, Stierner U, Wagenius G; Swedish Melanoma Study Group. Invasive cutaneous malignant melanoma in Sweden, 1990–1999 (2004) A prospective, population-based study of survival and prognostic factors. Cancer 101:2067–2078 Lindholm C, Andersson R, Dufmats M, Hansson J, Ingvar C, Möller T, Sjödin H, Stierner U, Wagenius G; Swedish Melanoma Study Group. Invasive cutaneous malignant melanoma in Sweden, 1990–1999 (2004) A prospective, population-based study of survival and prognostic factors. Cancer 101:2067–2078
go back to reference Mar V, Roberts H, Wolfe R et al (2013) Nodular melanoma: a distinct clinical entity and the largest contributor to melanoma deaths in Victoria, Australia. J Am AcadDermatol 68:568–575CrossRef Mar V, Roberts H, Wolfe R et al (2013) Nodular melanoma: a distinct clinical entity and the largest contributor to melanoma deaths in Victoria, Australia. J Am AcadDermatol 68:568–575CrossRef
go back to reference Pan Y, Adler NR, Wolfe R, McLean CA, Kelly JW (2017) Nodular melanoma is less likely than superficial spreading melanoma to be histologically associated with a naevus. Med J Aust 207:333–338CrossRef Pan Y, Adler NR, Wolfe R, McLean CA, Kelly JW (2017) Nodular melanoma is less likely than superficial spreading melanoma to be histologically associated with a naevus. Med J Aust 207:333–338CrossRef
go back to reference Pizzichetta MA, Massi D, Mandalà M, Queirolo P, Stanganelli I, De Giorgi V, Ghigliotti G, Cavicchini S, Quaglino P, Corradin MT, Rubegni P, Alaibac M, Astorino S, Ayala F, Magi S, Mazzoni L, Manganoni MA, Talamini R, Serraino D, Palmieri G; Italian Melanoma Intergroup (IMI) (2017) Clinicopathological predictors of recurrence in nodular and superficial spreading cutaneous melanoma: a multivariate analysis of 214 cases. J Transl Med 15(1):227 Pizzichetta MA, Massi D, Mandalà M, Queirolo P, Stanganelli I, De Giorgi V, Ghigliotti G, Cavicchini S, Quaglino P, Corradin MT, Rubegni P, Alaibac M, Astorino S, Ayala F, Magi S, Mazzoni L, Manganoni MA, Talamini R, Serraino D, Palmieri G; Italian Melanoma Intergroup (IMI) (2017) Clinicopathological predictors of recurrence in nodular and superficial spreading cutaneous melanoma: a multivariate analysis of 214 cases. J Transl Med 15(1):227
go back to reference Pollack LA, Li J, Berkowitz Z et al (2011) Melanoma survival in the US, 1992 to 2005. J Am AcadDermatol 65(5 Suppl 1):78–86 Pollack LA, Li J, Berkowitz Z et al (2011) Melanoma survival in the US, 1992 to 2005. J Am AcadDermatol 65(5 Suppl 1):78–86
go back to reference Ribero S, Gualano MR, Osella-Abate S, Scaioli G, Bert F, Sanlorenzo M, Balagna E, Fierro MT, Macripò G, Sapino A, Siliquini R, Quaglino P (2015) Association of histologic regression in primary melanoma with sentinel lymph node status: a systematic review and meta-analysis. JAMADermatol 151:1301–1307 Ribero S, Gualano MR, Osella-Abate S, Scaioli G, Bert F, Sanlorenzo M, Balagna E, Fierro MT, Macripò G, Sapino A, Siliquini R, Quaglino P (2015) Association of histologic regression in primary melanoma with sentinel lymph node status: a systematic review and meta-analysis. JAMADermatol 151:1301–1307
go back to reference Robsahm TE, Helsing P, Nilssen Y, Vos L, Rizvi SMH, Akslen LA, Veierød MB (2018) High mortality due to cutaneous melanoma in Norway: a study of prognostic factors in a nationwide cancer registry. ClinEpidemiol 10:537–548 Robsahm TE, Helsing P, Nilssen Y, Vos L, Rizvi SMH, Akslen LA, Veierød MB (2018) High mortality due to cutaneous melanoma in Norway: a study of prognostic factors in a nationwide cancer registry. ClinEpidemiol 10:537–548
go back to reference Sacchetto L, Zanetti R, Comber H et al (2018) Trends in incidence of thick, thin and in situ melanoma in Europe. Eur J Cancer 92:108–118CrossRef Sacchetto L, Zanetti R, Comber H et al (2018) Trends in incidence of thick, thin and in situ melanoma in Europe. Eur J Cancer 92:108–118CrossRef
go back to reference Shaikh WR, Xiong M, Weinstock MA (2012) The contribution of nodular subtype to melanoma mortality in the United States, 1978–2007. Arch Dermatol 148(1):30–36CrossRef Shaikh WR, Xiong M, Weinstock MA (2012) The contribution of nodular subtype to melanoma mortality in the United States, 1978–2007. Arch Dermatol 148(1):30–36CrossRef
go back to reference Tas F, Erturk K (2016) Presence of histological regression as a prognostic factor in cutaneous melanoma patients. Melanoma Res 26:492–496CrossRef Tas F, Erturk K (2016) Presence of histological regression as a prognostic factor in cutaneous melanoma patients. Melanoma Res 26:492–496CrossRef
go back to reference Whiteman DC, Green AC, Olsen CM (2016) The growing burden of invasive melanoma: projections of incidence rates and numbers of new cases in six susceptible populations through 2031. J Invest Dermatol 136:1161–1171CrossRef Whiteman DC, Green AC, Olsen CM (2016) The growing burden of invasive melanoma: projections of incidence rates and numbers of new cases in six susceptible populations through 2031. J Invest Dermatol 136:1161–1171CrossRef
Metadata
Title
Multivariate analysis of prognostic factors in patients with nodular melanoma
Authors
L. Susok
M. Stücker
F. G. Bechara
E. Stockfleth
T. Gambichler
Publication date
01-09-2021
Publisher
Springer Berlin Heidelberg
Published in
Journal of Cancer Research and Clinical Oncology / Issue 9/2021
Print ISSN: 0171-5216
Electronic ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-021-03562-1

Other articles of this Issue 9/2021

Journal of Cancer Research and Clinical Oncology 9/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.